Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 749575, 7 pages
http://dx.doi.org/10.1155/2009/749575
Research Article

Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy

1Department of Internal Medical Sciences, University of Cagliari, SS 554 Km 4.5, 09042 Monserrato, Italy
2International Observatory of Oxidative Stress, Free Radicals and Antioxidant Systems, Via Paolo Grisignano 21, 84127 Salerno, Italy
3Department of Biomedical Science and Technology, Division of Biochemistry, University of Cagliari, SS 554 Km 4.5, 09042 Monserrato, Italy

Received 10 February 2009; Revised 19 July 2009; Accepted 23 September 2009

Academic Editor: George Perry

Copyright © 2009 Antonella Mandas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Porter, “Survival after introduction of HAART in people with known duration of HIV-1 infection,” The Lancet, vol. 355, no. 9210, pp. 1158–1159, 2000. View at Google Scholar · View at Scopus
  2. “Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,” Developed by the panel on clinical practices for treatment of HIV infection convened by Department of Health and Human Service (DHHS), http://AIDSinfo.nih.gov.
  3. S. Grabar, V. Le Moing, C. Goujard et al., “Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy,” Annals of Internal Medicine, vol. 133, no. 6, pp. 401–410, 2000. View at Google Scholar · View at Scopus
  4. S. D. Fisher, T. L. Miller, and S. E. Lipshultz, “Impact of HIV and highly active antiretroviral therapy on leucocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis,” Atherosclerosis, vol. 185, pp. 1–11, 2006. View at Google Scholar
  5. C. Hadigan, “Diabetes, insulin resistance, and HIV,” Current Infectious Disease Reports, vol. 8, no. 1, pp. 69–75, 2006. View at Google Scholar · View at Scopus
  6. S. C. J. M. Vervoort, J. C. C. Borleffs, A. I. M. Hoepelman, and M. H. F. Grypdonck, “Adherence in antiretroviral therapy: a review of qualitative studies,” AIDS, vol. 21, no. 3, pp. 271–281, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. Halliwell, “Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?” The Lancet, vol. 344, no. 8924, pp. 721–724, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Schreck, P. Rieber, and P. A. Baeuerle, “Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1,” The EMBO Journal, vol. 10, no. 8, pp. 2247–2258, 1991. View at Google Scholar · View at Scopus
  9. I. I. Kruman, A. Nath, and M. P. Mattson, “HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress,” Experimental Neurology, vol. 154, no. 2, pp. 276–288, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. J. A. Martín, J. Sastre, J. De la Asunción, F. V. Pallardó, and J. Vinña, “Hepatic γ-cystathionase deficiency in patients with AIDS,” Journal of the American Medical Association, vol. 285, no. 11, pp. 1444–1445, 2001. View at Google Scholar · View at Scopus
  11. T. Hulgan, J. Morrow, R. T. D'Aquila et al., “Oxidant stress is increased during treatment of human immunodeficiency virus infection,” Clinical Infectious Diseases, vol. 37, no. 12, pp. 1711–1717, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. B. J. Day and W. Lewis, “Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo,” Cardiovascular Toxicology, vol. 4, no. 3, pp. 207–216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. N. Kumar, J. Dykstra, E. M. Roberts et al., “Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug-drug interaction,” Drug Metabolism and Disposition, vol. 27, no. 8, pp. 902–908, 1999. View at Google Scholar · View at Scopus
  14. W. Lewis, “Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions,” Antiviral Research, vol. 58, no. 3, pp. 189–197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cossarizza and G. Moyle, “Antiretroviral nucleoside and nucleotide analogues and mitochondria,” AIDS, vol. 18, no. 2, pp. 137–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. de La Asunción, M. L. del Olmo, J. Sastre et al., “AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins,” The Journal of Clinical Investigation, vol. 102, no. 1, pp. 4–9, 1998. View at Google Scholar · View at Scopus
  17. P. K. Drain, R. Kupka, F. Mugusi, and W. W. Fawzi, “Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy,” The American Journal of Clinical Nutrition, vol. 85, no. 2, pp. 333–345, 2007. View at Google Scholar · View at Scopus
  18. A. M. Tang, J. Lanzillotti, K. Hendricks et al., “Micronutrients: current issues for HIV care providers,” AIDS, vol. 19, no. 9, pp. 847–861, 2005. View at Google Scholar · View at Scopus
  19. P. A. Kirkham, G. Spooner, C. Ffoulkes-Jones, and R. Calvez, “Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor,” Free Radical Biology and Medicine, vol. 35, no. 7, pp. 697–710, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Helmersson, A. Larsson, B. Vessby, and S. Basu, “Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men,” Atherosclerosis, vol. 181, no. 1, pp. 201–207, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Dohi, K. Satoh, T. Nakamachi et al., “Does Edaravone (MCI-186) act as an antioxidant and a neuroproctetor in experimental traumatic brain injury?” Antioxid Redox Signal, vol. 9, pp. 281–287, 2007. View at Google Scholar
  22. R. Trotti, M. Carratelli, M. Barbieri et al., “Oxidative stress and a thrombophilic condition alcoholics without severe liver disease,” Haematologica, vol. 86, no. 1, pp. 85–91, 2001. View at Google Scholar · View at Scopus
  23. G. W. Pace and C. D. Leaf, “The role of oxidative stress in HIV disease,” Free Radical Biology and Medicine, vol. 19, no. 4, pp. 523–528, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. T. S. Dobmeyer, S. Findhammer, J. M. Dobmeyer et al., “Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection,” Free Radical Biology and Medicine, vol. 22, no. 5, pp. 775–785, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gil, G. Martínez, I. González et al., “Contribution to characterization of oxidative stress in HIV/AIDS patients,” Pharmacological Research, vol. 47, no. 3, pp. 217–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Ngondi, J. Oben, D. M. Forkah, L. H. Etame, and D. Mbanya, “The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon,” AIDS Research and Therapy, vol. 3, no. 1, p. 19, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. J. A. Aberg, “Lipid management in patients who have HIV and are receiving HIV therapy,” Endocrinology and Metabolism Clinics of North America, vol. 38, no. 1, pp. 207–222, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. Maffei, A. Mercuri, C. Prontera, G. C. Zucchelli, and C. Vassalle, “Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy,” Climacteric, vol. 9, no. 6, pp. 452–458, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. T. Ide, H. Tsutsui, N. Ohashi et al., “Greater oxidative stress in healthy young men compared with premenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 3, pp. 438–442, 2002. View at Publisher · View at Google Scholar · View at Scopus